|
|
Volumn 81, Issue 5, 2004, Pages 1424-1426
|
|
Clinically relevant differences and "Biocreep".
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FERTILITY PROMOTING AGENT;
FOLLITROPIN;
HUMAN MENOPAUSAL GONADOTROPIN;
RECOMBINANT PROTEIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COST;
ECONOMICS;
FEMALE;
FERTILIZATION IN VITRO;
HUMAN;
INTRACYTOPLASMIC SPERM INJECTION;
MALE;
METHODOLOGY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
DRUG COSTS;
FEMALE;
FERTILITY AGENTS, FEMALE;
FERTILIZATION IN VITRO;
FOLLICLE STIMULATING HORMONE;
HUMANS;
MALE;
MENOTROPINS;
RANDOMIZED CONTROLLED TRIALS;
RECOMBINANT PROTEINS;
RESEARCH DESIGN;
SPERM INJECTIONS, INTRACYTOPLASMIC;
|
|
EID: 2942694194
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/j.fertnstert.2004.03.003 Document Type: Letter |
|
Times cited : (1)
|
|
References (0)
|
